A team led by Stanley Hazen, MD, PhD, receives the first “Program Project” award focused on the gut microbiome. Three related research projects will be supported in a quest for new mechanistic and therapeutic insights.
Teasing Out the Role of Red Meat and TMAO in Cardiovascular Risk
Two new studies take significant steps toward interventions to reduce cardiac risk in humans by reducing levels of the metabolite TMAO through diet manipulation or targeted therapies.
Nonlethal Targeting of Gut Microbes Successfully Treats Atherosclerosis
The story linking gut microbes, TMAO and heart disease has turned toward therapy interventions with the first demonstrated targeting of a gut microbial pathway to curb diet-induced heart disease.